Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Informatic discovery of small molecules targeting human biology from Legionella pneumophila
EF 2012-13
Résumé
Bacteria are known to produce a variety of biologically active compounds to affect their environment; an observation that has lead to the discovery of many successful antibiotics. Some human pathogens also use bioactive molecules to advance disease, indicating that these compounds may be adapted for affecting human systems. Among bacterial pathogens that manipulate human processes, Legionella pneumophila is perhaps the most adept, converting hostile cells into complacent food sources within a few hours of infection. Extensive DNA sequencing has revealed that Legionella possesses several genes that may produce small molecules to control host cells during infection. Our laboratory has developed new methods of finding molecules from bacteria, and I intend to use these unique tools to identify the predicted drug-like molecules from Legionella. Initially, I have inactivated each of the genes responsible for producing these drug-like molecules, and have used these mutant bacteria to assess the role these chemicals may play in disease. Early results indicate that Legionella produces at least two complex new chemicals and that one of these plays an important role early in infection. Our laboratory is currently working to isolate these new chemicals to understand their structure and what component of human cells they might target. Further investigation of these initial results will explain how Legionella uses small molecules during infection, and may reveal novel human-targeted compounds that might be useful as chemical probes or as drugs for diseases of malfunctioning human systems, like cancer.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
283952
Name
Johnston Chad W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Informatic discovery of small molecules targeting human biology from Legionella pneumophila
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioactive Small Molecules; Drug Discovery; Genome Mining; Immunomodulatory; Infectious Disease; Legionella Pneumophila; Macrophage; Nonribosomal Peptide; Pathogenic Metabolites; Polyketide
Abstract
Bacteria are known to produce a variety of biologically active compounds to affect their environment; an observation that has lead to the discovery of many successful antibiotics. Some human pathogens also use bioactive molecules to advance disease, indicating that these compounds may be adapted for affecting human systems. Among bacterial pathogens that manipulate human processes, Legionella pneumophila is perhaps the most adept, converting hostile cells into complacent food sources within a few hours of infection. Extensive DNA sequencing has revealed that Legionella possesses several genes that may produce small molecules to control host cells during infection. Our laboratory has developed new methods of finding molecules from bacteria, and I intend to use these unique tools to identify the predicted drug-like molecules from Legionella. Initially, I have inactivated each of the genes responsible for producing these drug-like molecules, and have used these mutant bacteria to assess the role these chemicals may play in disease. Early results indicate that Legionella produces at least two complex new chemicals and that one of these plays an important role early in infection. Our laboratory is currently working to isolate these new chemicals to understand their structure and what component of human cells they might target. Further investigation of these initial results will explain how Legionella uses small molecules during infection, and may reveal novel human-targeted compounds that might be useful as chemical probes or as drugs for diseases of malfunctioning human systems, like cancer.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Johnston, Chad W
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~